09969.HK
InnoCare Pharma Limited
HKSE · Healthcare · Biotechnology · CN
HKD 15.37
+4.06%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 65.14x
- P/E 2027E
- 80.59x
- P/E 2028E
- 35.66x
- P/S forward
- 18.33x
Trailing multiples
Trailing twelve months
- P/E TTM
- 25.37x
- PEG TTM
- —
- Price / book
- 3.03x
- Price / sales
- 8.43x
- Price / cash flow
- 72.41x
Enterprise value
- Enterprise value
- HKD 19.9B
- EV / sales
- 6.21x
- EV / EBITDA
- 19.81x
- EV / EBIT
- 23.97x
- Market cap
- HKD 27.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026